{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:41:27Z","timestamp":1788594087156,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation | BCRF","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,6,5]]},"DOI":"10.1038\/s41416-026-03415-z","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:44:25Z","timestamp":1775497465000},"page":"1624-1632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Performance of an image-only deep learning breast cancer risk model with the addition of a polygenic risk score"],"prefix":"10.1038","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-1970","authenticated-orcid":false,"given":"Shadi","family":"Azam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie R.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3961-6609","authenticated-orcid":false,"given":"A. Heather","family":"Eliassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lindstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-6675","authenticated-orcid":false,"given":"Constance D.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2306-8668","authenticated-orcid":false,"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"3415_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-16399-0","volume-title":"Clinical Prediction Models A Practical Approach to Development, Validation, and Updating: Springer Science + Business Media LLC","author":"EW Steyerberg","year":"2019","unstructured":"Steyerberg EW Clinical Prediction Models A Practical Approach to Development, Validation, and Updating: Springer Science + Business Media LLC. New York: Springer; 2019."},{"key":"3415_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17130","volume":"17","author":"M Bond","year":"2013","unstructured":"Bond M, Pavey T, Welch K, Cooper C, Garside R, Dean S, et al. Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess. 2013;17:1\u2013170.","journal-title":"Health Technol Assess"},{"key":"3415_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0653-5","volume":"17","author":"AR Brentnall","year":"2015","unstructured":"Brentnall AR, Harkness EF, Astley SM, Donnelly LS, Stavrinos P, Sampson S, et al. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Res. 2015;17:147.","journal-title":"Breast Cancer Res"},{"key":"3415_CR4","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50:1219\u201324.","journal-title":"Nat Genet"},{"key":"3415_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.7326\/M20-5874","volume":"174","author":"N Zeinomar","year":"2021","unstructured":"Zeinomar N, Chung WK. Cases in precision medicine: the role of polygenic risk scores in breast cancer risk assessment. Ann Intern Med. 2021;174:408\u201312.","journal-title":"Ann Intern Med"},{"key":"3415_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","volume":"104","author":"N Mavaddat","year":"2019","unstructured":"Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet. 2019;104:21\u201334.","journal-title":"Am J Hum Genet"},{"key":"3415_CR7","doi-asserted-by":"publisher","first-page":"e1002644","DOI":"10.1371\/journal.pmed.1002644","volume":"15","author":"X Zhang","year":"2018","unstructured":"Zhang X, Rice M, Tworoger SS, Rosner BA, Eliassen AH, Tamimi RM, et al. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study. PLoS Med. 2018;15:e1002644.","journal-title":"PLoS Med"},{"key":"3415_CR8","doi-asserted-by":"crossref","unstructured":"Hughes E, Wagner S, Pruss D, Bernhisel R, Probst B, Abkevich V, et al. Development and validation of a breast cancer polygenic risk score on the basis of genetic ancestry composition. JCO Precis Oncol. 2022;6:e2200084.","DOI":"10.1200\/PO.22.00084"},{"key":"3415_CR9","doi-asserted-by":"crossref","unstructured":"Yala A, Mikhael PG, Strand F, Lin G, Smith K, Wan YL, et al. Toward robust mammography-based models for breast cancer risk. Sci Transl Med. 2021;13:eaba4373.","DOI":"10.1126\/scitranslmed.aba4373"},{"key":"3415_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrc1608","volume":"5","author":"GA Colditz","year":"2005","unstructured":"Colditz GA, Hankinson SE. The Nurses\u2019 Health Study: lifestyle and health among women. Nat Rev Cancer. 2005;5:388\u201396.","journal-title":"Nat Rev Cancer"},{"key":"3415_CR11","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/jnci\/90.17.1292","volume":"90","author":"SE Hankinson","year":"1998","unstructured":"Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1998;90:1292\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"3415_CR12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJM199109123251102","volume":"325","author":"MJ Stampfer","year":"1991","unstructured":"Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses\u2019 health study. N Engl J Med. 1991;325:756\u201362.","journal-title":"N Engl J Med"},{"key":"3415_CR13","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/archinte.166.14.1483","volume":"166","author":"RM Tamimi","year":"2006","unstructured":"Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med. 2006;166:1483\u20139.","journal-title":"Arch Intern Med"},{"key":"3415_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1148\/radiol.2018180694","volume":"290","author":"CD Lehman","year":"2019","unstructured":"Lehman CD, Yala A, Schuster T, Dontchos B, Bahl M, Swanson K, et al. Mammographic breast density assessment using deep learning: clinical implementation. Radiology. 2019;290:52\u20138.","journal-title":"Radiology"},{"key":"3415_CR15","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1200\/JCO.21.01337","volume":"40","author":"A Yala","year":"2022","unstructured":"Yala A, Mikhael PG, Strand F, Lin G, Satuluru S, Kim T, et al. Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model. J Clin Oncol 2022;40:1732\u201340.","journal-title":"J Clin Oncol"},{"key":"3415_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/ajcn\/nqaa316","volume":"113","author":"C Peng","year":"2021","unstructured":"Peng C, Gao C, Lu D, Rosner BA, Zeleznik O, Hankinson SE, et al. Circulating carotenoids and breast cancer among high-risk individuals. Am J Clin Nutr. 2021;113:525\u201333.","journal-title":"Am J Clin Nutr"},{"key":"3415_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ng.2563","volume":"45","author":"K Michailidou","year":"2013","unstructured":"Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45:353\u201361.61e1-2.","journal-title":"Nat Genet"},{"key":"3415_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou K, Lindstr\u00f6m S, Dennis J, Beesley J, Hui S, Kar S, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017;551:92\u20134.","journal-title":"Nature"},{"key":"3415_CR19","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879\u201386.","journal-title":"J Natl Cancer Inst"},{"key":"3415_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","volume":"93","author":"B Rockhill","year":"2001","unstructured":"Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93:358\u201366.","journal-title":"J Natl Cancer Inst"},{"key":"3415_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinforma. 2011;12:77.","journal-title":"BMC Bioinforma"},{"key":"3415_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10549-015-3641-7","volume":"154","author":"R Allman","year":"2015","unstructured":"Allman R, Dite GS, Hopper JL, Gordon O, Starlard-Davenport A, Chlebowski R, et al. SNPs and breast cancer risk prediction for African American and Hispanic women. Breast Cancer Res Treat. 2015;154:583\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"3415_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/jamaoncol.2017.4881","volume":"4","author":"EM van Veen","year":"2018","unstructured":"van Veen EM, Brentnall AR, Byers H, Harkness EF, Astley SM, Sampson S, et al. Use of single-nucleotide polymorphisms and mammographic density plus classic risk factors for breast cancer risk prediction. JAMA Oncol. 2018;4:476\u201382.","journal-title":"JAMA Oncol"},{"key":"3415_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10549-016-3953-2","volume":"159","author":"Y Shieh","year":"2016","unstructured":"Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JW, et al. Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Res Treat. 2016;159:513\u201325.","journal-title":"Breast Cancer Res Treat"},{"key":"3415_CR25","unstructured":"National Comprehensive Cancer Network (NCCN), Breast Cancer Screening and Diagnosis. Vesion 2.24. [Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1421."},{"key":"3415_CR26","unstructured":"National Comprehensive Cancer Network (NCCN). Breast Cancer Risk Reduction. version 2. 2025."},{"key":"3415_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1148\/radiol.2019182716","volume":"292","author":"A Yala","year":"2019","unstructured":"Yala A, Lehman C, Schuster T, Portnoi T, Barzilay R. A deep learning mammography-based model for improved breast cancer risk prediction. Radiology. 2019;292:60\u20136.","journal-title":"Radiology"},{"key":"3415_CR28","doi-asserted-by":"publisher","first-page":"e223077","DOI":"10.1148\/radiol.223077","volume":"308","author":"LR Lamb","year":"2023","unstructured":"Lamb LR, Mercaldo SF, Ghaderi K, Carney A, Lehman CD. Comparison of the diagnostic accuracy of mammogram-based deep learning and traditional breast cancer risk models in patients who underwent supplemental screening with MRI. Radiology. 2023;308:e223077.","journal-title":"Radiology"},{"key":"3415_CR29","doi-asserted-by":"publisher","first-page":"e222733","DOI":"10.1148\/radiol.222733","volume":"307","author":"VA Arasu","year":"2023","unstructured":"Arasu VA, Habel LA, Achacoso NS, Buist DSM, Cord JB, Esserman LJ, et al. Comparison of mammography AI algorithms with a clinical risk model for 5-year breast cancer risk prediction: an observational study. Radiology. 2023;307:e222733.","journal-title":"Radiology"},{"key":"3415_CR30","doi-asserted-by":"publisher","first-page":"e250391","DOI":"10.1148\/radiol.250391","volume":"317","author":"JWD Rothwell","year":"2025","unstructured":"Rothwell JWD, Rogers P, Payne NR, Huang Y, Kaggie JD, Hickman SE, et al. Evaluation of a mammography-based deep learning model for breast cancer risk prediction in a triennial screening program. Radiology. 2025;317:e250391.","journal-title":"Radiology"},{"key":"3415_CR31","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/jnci\/djac142","volume":"114","author":"CD Lehman","year":"2022","unstructured":"Lehman CD, Mercaldo S, Lamb LR, King TA, Ellisen LW, Specht M, et al. Deep learning vs traditional breast cancer risk models to support risk-based mammography screening. J Natl Cancer Inst. 2022;114:1355\u201363.","journal-title":"J Natl Cancer Inst"},{"key":"3415_CR32","unstructured":"Division IMI. Mammography departments expect budgets to grow by nearly 10%. 2023."},{"key":"3415_CR33","doi-asserted-by":"crossref","unstructured":"Polygenic Risk Score Task Force of the International Common Disease Alliance. Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. Nat Med. 2021;27:1876\u20131884.","DOI":"10.1038\/s41591-021-01549-6"},{"key":"3415_CR34","doi-asserted-by":"publisher","first-page":"910","DOI":"10.21037\/tlcr-21-698","volume":"11","author":"RJ Klein","year":"2022","unstructured":"Klein RJ, G\u00fcm\u00fc\u015f ZH. Are polygenic risk scores ready for the cancer clinic?-a perspective. Transl Lung Cancer Res. 2022;11:910\u20139.","journal-title":"Transl Lung Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03415-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03415-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03415-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:07:21Z","timestamp":1779088041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03415-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,6,5]]}},"alternative-id":["3415"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03415-z","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The study protocol was approved by the Institutional Review Boards of Brigham and Women\u2019s Hospital and the Harvard T.H. Chan School of Public Health, as well as by the ethics committees of participating cancer registries, as required (Protocol No. 1999P002112). Informed consent was obtained from all participants prior to their inclusion in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"C Lehman is a co-founder of and consultant to Clairity, Inc., and receives institutional grant support from GE Healthcare, Inc. All other authors disclosed no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}